---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000486"
form_type: "8-K"
ticker: "LCTC"
cik: "0001493137"
company_name: "Lifeloc Technologies, Inc"
filed_at: "2024-04-02T23:59:59+00:00"
generated_at: "2026-06-04T03:30:02.864468+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lifeloc reports 2023 revenue $9.33M, net profit $206K vs loss prior year

## Summary
- Net revenue $9.330M (+10% YoY); net profit $206K ($0.08 diluted EPS) vs net loss $456K ($0.19 loss) in 2022.
- Gross margin improved to 43.3% from 36.3% due to price increases, lower depreciation, easing supply constraints.
- R&D investment increased 32% YoY focused on SpinDx 'Lab on a Disk' drug detection platform.
- Beta testing of SpinDx delta-9-THC saliva test expected later 2024; commercialization projected 2025.
- CEO says supply constraints no longer significant; L-series devices gaining approvals and market penetration.

## SEC filing metadata
- accession: 0001079973-24-000486
- form_type: 8-K
- ticker: LCTC
- cik: 0001493137
- company_name: Lifeloc Technologies, Inc
- filed_at: 2024-04-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493137/000107997324000486/0001079973-24-000486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493137/000107997324000486/lclc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000486
- JSON: https://secwatch.observer/filing/0001079973-24-000486.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000486.txt

## Key facts
- Earnings Releases
  Lifeloc Technologies, Inc reported fiscal year ended December 31, 2023 results: revenue $9.330 million, net income $206 thousand, EPS $0.08 per diluted share.
  - Period: fiscal year ended December 31, 2023
  - Revenue: $9.330 million
  - Net income: $206 thousand
  - EPS: $0.08 per diluted share
  - Result: reported results
  source text: Lifeloc Technologies posted annual net revenue of $9.330 million resulting in a net profit of $206 thousand in 2023, or $0.08 per diluted share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1493137/000107997324000486/0001079973-24-000486-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.